Results 151 to 160 of about 174,741 (390)

News in Pathogenesis of Chronic Venous Insufficiency

Acta Medica Martiniana, 2016
This review article is concentrating on the news in the pathophysiology of chronic venous insufficiency (CVD). Despite ongoing progress in understanding the molecular aspects of CVD the exact mechanism of its development remains unclear.
Mazuchova J, Pec M, Halasova E, Valentova V, Sarlinova M, Mazuch J, Zelnik S   +6 more
doaj   +1 more source

Investigation of Chronic Venous Insufficiency [PDF]

, 2000
Andrew Nicolaides
openalex   +1 more source

Development and evaluation of an impedance cardiographic system to measure cardiac output and other cardiac parameters Final progress report 1 Jul. 1969 - 31 Dec. 1970 [PDF]

Performance of impedance cardiograph for measuring heart rate and body ...
From, A. H. L., Kubicek, W. G., Patterson, R. P., Witsoe, D. A.   +3 more
core   +1 more source

HIV-associated multi-centric Castleman’s disease with multiple organ failure: cuccessful treatment with rituximab [PDF]

, 2010
Introduction: Multicentric Castleman's Disease (MCD), a lymphoproliferative disorder associated with Human Herpes Virus-8 (HHV-8) infection, is increasing in incidence amongst HIV patients.
Agarwal, B, Cleverley, JR, Cwynarski, K, Doyle, T, Isaacson, PG, Johns, RH, Lipman, M, Shaw, S   +7 more
core  

CircSMEK1 Suppresses HCC via the hnRNPK‐IGF2‐AKT Axis: A Diagnostic Biomarker and Therapeutic Target

Advanced Science, EarlyView.
CircSMEK1 is downregulated in MASH/HCC and predicts poor prognosis. It suppresses tumor progression by promoting hnRNPK ubiquitination and inhibiting the IGF2/PI3K/AKT axis, while its loss activates immunosuppressive cancer‐associated fibroblasts. Serum circSMEK1 serves as a non‐invasive diagnostic biomarker, and its restoration potently inhibits HCC ...
Peilan Guo, Xiaomeng Jia, Shenghong Wang, Xinyu Li, Yajing Liu, Lisen Lin, Zhengkun Wang, Fujun Liu, Slawomir Wolczynski, Nafis Rahman, Jie Gao, Xuguang Du, Suk‐Ying Tsang, Jiali Liu, Wei Song, Xiangdong Li   +15 more
wiley   +1 more source

Peculiarities of drug therapy of lower extremities chronic venous insufficiency

Амбулаторная хирургия, 2016
Chronic vein diseases (CVD) depending on the design and evaluation criteria of conducted epidemiologic studies are diagnosed in 20-85% of adult residents of industrially developed countries.
V. Y. Bogachev, B. V. Boldin, O. V. Dzhenina, V. N. Lobanov   +3 more
doaj  

Target selection for surgical intervention in severe chronic venous insufficiency: Comparison of duplex scanning and phlebography [PDF]

, 2000
Ralph G. DePalma, Donna L. Kowallek, Thomas C. Barcia, H.Treat Cafferata   +3 more
openalex   +1 more source

Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiency.

Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2020
R. Kolluri, Janice Chung, Sue Kim, Nibir Nath, B. B. Bhalla, Tarun Jain, J. Zygmunt, A. Davies   +7 more
semanticscholar   +1 more source

LPS‐Induced Mitochondrial Damage via SLC41A1‐Mediated Magnesium Ion Efflux Leads to the Pyroptosis of Dental Stem Cells

Advanced Science, EarlyView.
Lipopolysaccharide induces upregulation of the magnesium (Mg2+) efflux transporter solute carrier family 41 member 1 in dental stem cells, leading to a decrease in intracellular Mg2+ concentration and promoting the binding of oligomycin sensitivity‐conferring protein and cyclophilinD.
Yuan Liu, Chenyu Song, Liyuan Zhang, Xue Han, Chaoyuan Li, Yanhong Yan, Ludan Xing, Mengting Si, Bo Yang, Lingyuan Cheng, Akimi Muramatsu, Beizhan Jiang   +11 more
wiley   +1 more source

Novel mechanical thrombectomy device used to restore patency to chronically occluded deep venous bypasses

Journal of Vascular Surgery Cases and Innovative Techniques
Long-standing venous thrombosis can result in chronic venous occlusions, ultimately leading to chronic venous insufficiency and venous ulcerations, a condition known as post-thrombotic syndrome.
Georges Jreij, MD, Georg J. Furtmüller, MD, Eleanor Dunlap, CRNP, DNP, Khanjan Nagarsheth, MD, MBA   +3 more
doaj   +1 more source